spironolactone (Aldactone) is beneficial for heart failure will change prescribing habits

August 1999

The exciting new finding that spironolactone (Aldactone) is beneficial for heart failure will change prescribing habits.

Researchers saw such significant improvement that they stopped the study early. The New England Journal of Medicine released the article over a month before it was scheduled to be published.

Adding spironolactone to the usual therapy for severe CHF improves symptoms...and reduces mortality and hospitalization by 30%.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: PA includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote